Search This Blog

Wednesday, June 17, 2026

Morgan Stanley downgrades ResMed to Equal Weight, cuts price target to $230 from $286

 


  • Firm cites expectations of slower revenue growth as Philips re-enters the U.S. device market.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)